Lindsey Sachs is a fourth-year UF student majoring in microbiology with a minor in health disparities in society. Lindsey joined the Brusko Lab in the Spring of 2021 and is passionate about building a strong knowledge base centered on the human immune response, autoimmunity, and immunological experimental design. She is currently involved in investigating the therapeutic potential of modulating the CD226/TIGIT costimulatory pathway for the development of therapeutics to treat Type 1 Diabetes.
Abstracts & Presentations
- Brown ME, Arnoletti JM, Sachs LK, Nguyen KQ, Lee JJ, Brusko TM. CD226– Human Regulatory T Cells Exhibit Increased Stability Compared to Conventionally Sorted Populations. Poster presented at: 18th Congress of the Immunology of Diabetes Society (IDS); 2021 Nov 1-4; Virtual. (Outstanding Abstract Award Received)
Lab: (352) 273-9300